Kozek-Langenecker S A
Abteilung für Spezielle Anästhesie und Schmerztherapie, Univ-Klinik für Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090 Wien, Osterrreich.
Anaesthesist. 2008 Jun;57(6):597-606. doi: 10.1007/s00101-008-1347-5.
The options for drug-controlled anticoagulation are becoming noticeably more manifold. In the area of anaesthesiology and intensive care, there are furthermore special disease patterns, such as heparin-induced thrombocytopenia (HIT) to be known, diagnosed and treated. This article gives a review of the substance groups of the direct thrombin inhibitors (DTI) as alternative anticoagulants for HIT in combination with cardiovascular diseases. For the administration of DTIs, experience and the correct dose are the keys to success and are the deciding factors for the two sides of haemostasis: thrombosis and haemorrhage.
药物控制抗凝的选择正变得明显更加多样。在麻醉学和重症监护领域,此外还有一些特殊的疾病模式,如肝素诱导的血小板减少症(HIT)需要了解、诊断和治疗。本文综述了直接凝血酶抑制剂(DTI)这一药物类别,作为HIT合并心血管疾病时的替代抗凝剂。对于DTI的给药,经验和正确剂量是成功的关键,也是止血两个方面(血栓形成和出血)的决定性因素。